BC
MRVI icon

Brookfield Corp’s Maravai LifeSciences MRVI Stock Holding History

Brookfield Corp’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-97,854
Closed -$1.22M – 375
2023
Q2 		$1.22M Sell
97,854
-61,191
-38% -$826K ﹤0.01% 452
2023
Q1 		$2.23M Buy
159,045
+72,966
+85% +$1.05M 0.01% 409
2022
Q4 		$1.23M Sell
86,079
-388,243
-82% -$6.11M ﹤0.01% 479
2022
Q3 		$12.1M Buy
474,322
+16,682
+4% +$419K 0.04% 143
2022
Q2 		$13M Buy
457,640
+397,640
+663% +$12.6M 0.05% 119
2022
Q1 		$2.12M Buy
60,000
+29,098
+94% +$975K 0.01% 387
2021
Q4 		$1.29M Sell
30,902
-15,559
-33% -$630K 0.01% 401
2021
Q3 		$2.28M Buy
+46,461
New +$2.27M 0.01% 327

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Brookfield Corp's MRVI Position: Q3 2023 in Review

Brookfield Corp sold out of Maravai LifeSciences (MRVI) in Q3 2023, closing a stake of 97,854 shares — an estimated $1.22M sold.

Brookfield Corp first reported a position in MRVI in Q3 2021 and held it in 8 quarters. The position peaked at $13M in Q2 2022. 205 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

  • Brookfield Corp reported no remaining Maravai LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 97,854 Maravai LifeSciences shares in Q3 2023, an estimated $1.22M.
  • Brookfield Corp first reported a position in Maravai LifeSciences in Q3 2021 and held it in 8 quarters.
  • Brookfield Corp's Maravai LifeSciences position peaked at $13M in Q2 2022.
  • 205 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.